BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26123483)

  • 1. A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome.
    Soundararajan R; Paranjape AN; Barsan V; Chang JT; Mani SA
    Sci Rep; 2015 Jun; 5():11766. PubMed ID: 26123483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
    Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
    Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
    D'Amato NC; Ostrander JH; Bowie ML; Sistrunk C; Borowsky A; Cardiff RD; Bell K; Young LJ; Simin K; Bachelder RE; Delrow J; Dawson A; Yee LD; Mrózek K; Clay TM; Osada T; Seewaldt VL
    PLoS One; 2012; 7(9):e45684. PubMed ID: 23049838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
    Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
    Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.
    Lenfert E; Maenz C; Heinlein C; Jannasch K; Schumacher U; Pantel K; Tolstonog GV; Deppert W; Wegwitz F
    Int J Cancer; 2015 Mar; 136(6):E521-33. PubMed ID: 25195563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
    Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
    Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
    Slabáková E; Kharaishvili G; Smějová M; Pernicová Z; Suchánková T; Remšík J; Lerch S; Straková N; Bouchal J; Král M; Culig Z; Kozubík A; Souček K
    Oncotarget; 2015 Nov; 6(34):36156-71. PubMed ID: 26416355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity.
    Beerling E; Seinstra D; de Wit E; Kester L; van der Velden D; Maynard C; Schäfer R; van Diest P; Voest E; van Oudenaarden A; Vrisekoop N; van Rheenen J
    Cell Rep; 2016 Mar; 14(10):2281-8. PubMed ID: 26947068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
    Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
    Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-200-containing extracellular vesicles promote breast cancer cell metastasis.
    Le MT; Hamar P; Guo C; Basar E; Perdigão-Henriques R; Balaj L; Lieberman J
    J Clin Invest; 2014 Dec; 124(12):5109-28. PubMed ID: 25401471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
    Ismail IA; Kang HS; Lee HJ; Chang H; Yun J; Lee CW; Kim NH; Kim HS; Yook JI; Hong SH; Kwon BM
    Breast Cancer Res Treat; 2013 Feb; 137(3):697-708. PubMed ID: 23283523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
    Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.